Observing Chronic Lymphoid Leukaemia Patients in Finistere, France
Chronic Lymphoid Leukaemia Observatory in Finistere Area, France
This study is collecting information about people with Chronic Lymphoid Leukaemia in Finistere, France, to understand their characteristics, treatments, and how their disease progresses.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 1 site (Brest) |
| Trial ID | NCT03294980 on ClinicalTrials.gov |
What this trial studies
The OFICE registry is a prospective observational project aimed at characterizing the population of patients with Chronic Lymphoid Leukaemia (CLL) in the Finistere area of France. It will collect data on patient characteristics, treatment patterns, and healthcare resource utilization, while also evaluating the relationship between cytogenetic and immunophenotypic features and disease progression. This registry will serve as a valuable resource for researchers and healthcare providers to enhance clinical practice and inform future studies.
Who should consider this trial
Good fit: Ideal candidates for this registry are adults aged 18 and older with a clinical diagnosis of CLL or SLL.
Not a fit: Patients with other B-cell malignancies will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could improve understanding of CLL and lead to better treatment strategies for patients.
How similar studies have performed: While observational studies in CLL have been conducted, this specific registry approach is novel for the Finistere region.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age of at least 18 years * Clinical diagnosis of CLL/SLL that meets published diagnostic criteria (Hallek 2008) * Willing and able to provide informed consent * Willing and able to provide blood sample at time of enrollment Exclusion Criteria: * Diagnosis of other B-cell malignancies
Where this trial is running
Brest
- CHRU de Brest — Brest, France (Recruiting)
Study contacts
- Study coordinator: Yves Renaudineau
- Email: yves.renaudineau@chu-brest.fr
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.